PDS Biotechnology Corporation Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.33 | -$0.33 | -$0.33 |
Q2 2024 | 4 | -$0.34 | -$0.27 | -$0.30 |
Q3 2024 | 1 | -$0.33 | -$0.33 | -$0.33 |
Q1 2025 | 2 | -$0.33 | -$0.33 | -$0.33 |
Q2 2025 | 2 | -$0.34 | -$0.34 | -$0.34 |
Q3 2025 | 2 | -$0.34 | -$0.34 | -$0.34 |
Q4 2025 | 2 | -$0.35 | -$0.35 | -$0.35 |
PDS Biotechnology Corporation Earnings Date And Information
PDS Biotechnology Corporation last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.23 earnings per share for the quarter, topping analysts' consensus estimates of $-0.31 by $0.08. The company had revenue of 0 for the quarter and had revenue of 0 for the year. PDS Biotechnology Corporation has generated $-1 earnings per share over the last year ($-1.39 diluted earnings per share) and currently has a price-to-earnings ratio of -2.97. PDS Biotechnology Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
PDS Biotechnology Corporation Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/13/2024 | Q2 2024 | -$0.31 | -$0.23 | 0.08 | $0 | $0 |
03/29/2024 | Q1 2024 | -$0.30 | $0 | |||
12/29/2023 | Q4 2023 | -$0.34 | $0 | |||
11/14/2023 | Q3 2023 | -$0.42 | -$0.35 | 0.07 | $0 | |
08/14/2023 | Q2 2023 | -$0.37 | -$0.37 | 0 | $0 | |
05/15/2023 | Q1 2023 | -$0.31 | -$0.32 | -0.01 | $0 | |
04/28/2023 | Q4 2022 | -$0.75 | $0 | |||
11/14/2022 | Q3 2022 | -$0.26 | -$0.26 | 0 | $0 | |
08/08/2022 | Q2 2022 | -$0.30 | -$0.20 | 0.1 | $0 | |
05/11/2022 | Q1 2022 | -$0.24 | -$0.32 | -0.08 | $0 | |
03/31/2022 | Q4 2021 | -$0.24 | -$0.22 | 0.02 | $0 | |
11/10/2021 | Q3 2021 | -$0.22 | -$0.24 | -0.02 | $0 | |
08/12/2021 | Q2 2021 | -$0.21 | -$0.03 | 0.18 | $0 | |
05/13/2021 | Q1 2021 | -$0.20 | -$0.14 | 0.06 | $0 | |
03/18/2021 | Q4 2020 | -$0.18 | -$0.26 | -0.08 | $0 | |
11/13/2020 | Q3 2020 | -$0.21 | $0 | |||
08/13/2020 | Q2 2020 | -$0.26 | -$0.19 | 0.07 | $0 | |
05/13/2020 | Q1 2020 | -$0.15 | -$0.39 | -0.24 | $0 | |
03/27/2020 | Q4 2019 | -$0.92 | -$0.41 | 0.51 | $0 | |
11/07/2019 | Q3 2019 | -$0.84 | -$1.10 | -0.26 | $0 |
PDS Biotechnology Corporation Earnings: Frequently Asked Questions
-
When is PDS Biotechnology Corporation's earnings date?
PDS Biotechnology Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
Did PDS Biotechnology Corporation beat their earnings estimates last quarter?
In the previous quarter, PDS Biotechnology Corporation (:PDSB) reported $-0.23 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.31 by $0.08.
-
How can I listen to PDS Biotechnology Corporation's earnings conference call?
The conference call for PDS Biotechnology Corporation's latest earnings report can be listened to online.
-
How can I read PDS Biotechnology Corporation's conference call transcript?
The conference call transcript for PDS Biotechnology Corporation's latest earnings report can be read online.
-
How much profit does PDS Biotechnology Corporation generate each year?
PDS Biotechnology Corporation (:PDSB) has a recorded net income of $0. PDS Biotechnology Corporation has generated $-1.39 earnings per share over the last four quarters.
-
What is PDS Biotechnology Corporation's price-to-earnings ratio?
PDS Biotechnology Corporation (:PDSB) has a price-to-earnings ratio of -2.97 and price/earnings-to-growth ratio is -0.29.